Xenofon Baraliakos, MD, PhD, discusses significant improvements in BASDAI and ASDAS scores in new late-breaking data from EULAR 2026.
Xenofon Baraliakos, MD, PhD
Advertisement
Head of Rheumatology at the Rheumazentrum Ruhrgebiet, Herne, Germany, and Professor for Internal Medicine and Rheumatology at the Ruhr-University Bochum, Germany.
Articles by Xenofon Baraliakos, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Rheumatology Live
1
Joint Ventures: CAR-T, Early Diagnosis Reshape Scleroderma at EULAR 2026
2
Sonelokimab Reduces Inflammation, Osteoblastic Activity in Phase 2 Proof-of-Concept axSpA Study
3
Slow But Steady: Real-World Data Supports Avacopan Use in GPA/MPA
4
Nipocalimab Demonstrates Proof of Concept for FcRn Blockade for SLE
5